Skip to main content

Diagnostic options Β· UAE

Deafness Genetic tests in Dubai & UAE

Compare available Deafness Genetic tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

9

Listed price range

2,800.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Deafness Genetic test prices

Showing 1–9 of 9 matching tests.

Deafness Genetic diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-5695
CLDN14 Gene Autosomal Recessive Deafness Type 29 (DFNB29) Genetic Test

This genetic test evaluates the CLDN14 gene for pathogenic variants associated with autosomal recessive nonsyndromic deafness type 29 (DFNB29).

Peripheral Whole Blood (EDTA) or FTA Card 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["CLDN14 gene sequence", "Pathogenic variants in CLDN14"]
Parameters
[]
Preparation
["Provide detailed family and clinical history of hearing loss", "Genetic counseling session recommended"]
Indications
["Suspected DFNB29", "Family history of DFNB29", "Genetic counseling for hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 82272-3 ICD-10: H90.3
Clinical summary
This genetic test evaluates the CLDN14 gene for pathogenic variants associated with autosomal recessive nonsyndromic deafness type 29 (DFNB29).
TEST-5742
MYO1A Gene Autosomal Dominant Deafness Type 48 (DFNA48) Genetic Test

This genetic test evaluates the MYO1A gene for mutations associated with autosomal dominant non-syndromic hearing loss (DFNA48). It provides a definitive molecular diagnosis for th...

Whole blood (EDTA), extracted DNA, or FTA card 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["MYO1A gene sequence", "Copy Number Variations (CNVs) in MYO1A"]
Parameters
[]
Preparation
[]
Indications
["Suspected autosomal dominant non-syndromic hearing loss (DFNA48)", "Genetic counselling for hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21674-2 ICD-10: Z13.79
Clinical summary
This genetic test evaluates the MYO1A gene for mutations associated with autosomal dominant non-syndromic hearing loss (DFNA48). It provides a definitive molecular diagnosis for this specific type of inherited hearing loss.
TEST-5586
OTOF Gene Deafness (Autosomal Recessive Type 9) Genetic Test

This test identifies pathogenic variants in the OTOF gene associated with autosomal recessive nonsyndromic hearing loss (DFNB9).

Whole Blood (EDTA), Extracted DNA, or FTA Card 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the OTOF gene", "Detection of point mutations, indels, and CNVs"]
Parameters
[]
Preparation
[]
Indications
["Newborns and children with unexplained bilateral sensorineural hearing loss", "Evaluation for cochlear implant candidacy", "Family history of DFNB9"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81247-9 ICD-10: H90.5, H90.3
Clinical summary
This test identifies pathogenic variants in the OTOF gene associated with autosomal recessive nonsyndromic hearing loss (DFNB9).
TEST-5772
POU4F3 Gene Deafness (Autosomal Dominant Type 15) Genetic Test

This genetic test identifies pathogenic variants in the POU4F3 gene associated with autosomal dominant non-syndromic sensorineural hearing loss (DFNA15).

Blood (whole blood, extracted DNA, or FTA card) 3–4 Weeks from sample receipt 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the POU4F3 gene", "Deletion/duplication analysis (CNV detection) of the POU4F3 gene"]
Parameters
[]
Preparation
[]
Indications
["Suspected autosomal dominant non-syndromic sensorineural hearing loss (DFNA15)", "Family history suggestive of DFNA15", "Diagnosis confirmation for hearing loss of unknown cause"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 48304-3 ICD-10: H90.3
Clinical summary
This genetic test identifies pathogenic variants in the POU4F3 gene associated with autosomal dominant non-syndromic sensorineural hearing loss (DFNA15).
TEST-5639
SERPINB6 Gene Deafness, Autosomal Recessive Type 91 Genetic Test

This genetic test identifies mutations in the SERPINB6 gene associated with autosomal recessive deafness type 91.

5 mL EDTA whole blood, dried blood spot on FTA card, or 2 Β΅g extracted DNA 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["SERPINB6 gene sequence", "Copy Number Variations (CNV) in SERPINB6"]
Parameters
[]
Preparation
["No fasting required", "No dietary restrictions", "No medication adjustments necessary"]
Indications
["Confirmation of suspected DFNB91", "Genetic cause of hearing loss", "Family risk assessment", "Reproductive planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81225-8 ICD-10: H90.3, Z82.2, Z14.8
Clinical summary
This genetic test identifies mutations in the SERPINB6 gene associated with autosomal recessive deafness type 91.
TEST-5718
STRC Gene (Autosomal Recessive Deafness Type 16) Genetic Test

This genetic test evaluates the STRC gene for pathogenic variants associated with autosomal recessive deafness type 16 (DFNB16).

Whole Blood or Dried Blood Spot (DBS) 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the STRC gene", "Single-nucleotide variants", "Copy number variations"]
Parameters
[]
Preparation
["A mandatory pre-test genetic counselling session is required."]
Indications
["Suspected autosomal recessive deafness type 16 (DFNB16)", "Family history of STRC-related hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81319-1 ICD-10: H90.5
Clinical summary
This genetic test evaluates the STRC gene for pathogenic variants associated with autosomal recessive deafness type 16 (DFNB16).
TEST-5656
USH1C Gene (DFNB18) Sequencing: Autosomal Recessive Deafness Type 18 Genetic Test

This test analyzes the USH1C gene to detect mutations associated with autosomal recessive deafness type 18 (DFNB18) and Usher syndrome type 1C.

Whole Blood (3–5 mL EDTA tube), Extracted DNA, or Dried Blood Spot (FTA Card) 3 – 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the USH1C gene", "Coverage of coding exons, intron-exon boundaries, and deep intronic regions"]
Parameters
[]
Preparation
["No fasting required", "Inform phlebotomist about bleeding tendencies or anticoagulant use"]
Indications
["Individuals with congenital hearing loss", "Individuals with a family history of hereditary deafness", "Individuals with clinical features suggestive of Usher syndrome"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94227-2 ICD-10: H90.3, H90.5
Clinical summary
This test analyzes the USH1C gene to detect mutations associated with autosomal recessive deafness type 18 (DFNB18) and Usher syndrome type 1C.
TEST-5734
WFS1 Gene Deafness Autosomal Dominant Type 6 Genetic Test

This test evaluates the WFS1 gene for pathogenic variants associated with autosomal dominant non-syndromic hearing loss, specifically DFNA6.

Whole blood (peripheral), extracted DNA, or FTA card blood spot 3–4 weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the WFS1 gene", "Copy-number variants (CNVs) within the WFS1 gene"]
Parameters
[]
Preparation
["Pre-test genetic counselling is required", "Provide a three-generation pedigree chart"]
Indications
["Suspected autosomal dominant non-syndromic hearing loss (DFNA6)", "Family history of DFNA6", "Genetic counseling for hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21636-6 ICD-10: H90.3
Clinical summary
This test evaluates the WFS1 gene for pathogenic variants associated with autosomal dominant non-syndromic hearing loss, specifically DFNA6.
TEST-5634
WHRN Gene Deafness, Autosomal Recessive Type 31 Genetic Test

This test detects pathogenic variants in the WHRN gene associated with autosomal recessive non-syndromic sensorineural hearing loss (DFNB31) and Usher syndrome type 2D.

Peripheral Whole Blood or FTA Card Finger-Prick 3–4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the WHRN gene", "Copy Number Variations (CNV) in the WHRN gene"]
Parameters
[]
Preparation
["No specific fasting required", "Inform phlebotomist of any medications"]
Indications
["Diagnosis of non-syndromic sensorineural hearing loss", "Diagnosis of Usher syndrome type 2D", "Genetic counseling for families with hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 55233-1 ICD-10: H90.3
Clinical summary
This test detects pathogenic variants in the WHRN gene associated with autosomal recessive non-syndromic sensorineural hearing loss (DFNB31) and Usher syndrome type 2D.

Category overview

Deafness Genetic: overview

When a family history of hearing loss points toward a specific hereditary trait, getting precise molecular confirmation is crucial for proactive family planning and medical management. Representing a highly focused tool in our Molecular Genetics services, Deafness Genetic testing meticulously targets the exact DNA mutation responsible for your family's unique auditory condition. By leveraging state-of-the-art sequencing technology, this precise genomic screening provides the definitive data needed to assess carrier status, evaluate risks for future children, and safely guide tailored pediatric interventions. Consistently trusted by ENTs and audiologists across the best diagnostic labs in Dubai and the UAE, DNA Labs ensures strict patient confidentiality, unparalleled diagnostic accuracy, and highly efficient reporting. Secure the critical diagnostic insights your family deservesβ€”book your deafness genetic testing in UAE, arrange a seamless home sample collection, or connect with our specialized genetic counselors today.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.